Compression Therapy Market

Market Snapshot

Vein disorders like lymphedema, deep vein thrombosis, leg ulcers, varicose veins, blood clots have been on a substantial rise since the last few years. As per the NCBI, close to 50% of the global population is affected by chronic vein abnormalities.

Bandages and stockings are amongst the most commonly used compression therapy products. Besides, compression works wonders in orthopaedic surgeries for alleviating pain, reducing swelling, and facilitating speedy functional recovery.

The benefits mentioned above hold the responsibility of high penetration of compression therapy products in managing musculoskeletal injuries post-operative orthopaedic procedures.

Compression garments also find their presence in sports medicines these days. Also, compression therapy is being used at a large scale for preventing swelling and inflammation following a trauma or an injury.

The other applications include enabling blood circulation and preventing fluids’ coagulation in the tissue space, thereby fostering mental health.

Additionally, intraoperative sequential compression device systems are being used especially when prolonged laparoscopic surgery comes into picture. The basic objective is that of countering altered venous blood return through lower extremities and resultant cardiac depression due to pneumoperitoneum.

Sequential compression has been reported to generate results within a couple of hours every single day in comparison with the other alternatives taking 12-48 hours for obtaining the same result.

Compression Therapy Market Trends

The compression therapy market players are into the expansion mode to sustain their foothold. These measures are likely to take the market at greater strides in the forecast period (2020-2030).

For instance –

• AIROS, in May 2020, launched its US FDA-approved updated AIROS 6 Sequential Compression Therapy device and Arm Plus garments to be used for treating lymphedema in chest, shoulder, arm, and back
• Paul Hartmann, recently came up with VivanoTec Y-Connector to be used in NPWT (Negative Pressure Wound Therapy)
• 3M’s Coban 2 Layer Compression System has been designed for reducing application variability regarding consistency in compression
• Sigvaris AG, in Apr 2018, launched an updated version of SAMSON stockings made up of skin-friendly cotton that keep away from moisture
• Huntleigh, in the year 2017, tabled “Lymphassist”, the homecare alternating compression system to facilitate self-management on the part of Lymphodema

Regional Analysis

Download a Comprehensive Report Snapshot

North America compression therapy market continues to be the most lucrative. This could be attributed to increase in the feasible reimbursement scenario along with growing number of sports and orthopaedic injuries.

Europe compression therapy market is the second largest, more so due to the fact that as per the NCBI, the western countries reported the highest number of chronic venous disorders (1-17% in males and 15-40% in females).

Asia-Pacific is expected to grow at the fastest rate during the forecast period (2020-2030). India and China are home to the highest number of diabetic patients as per the International Diabetes Federation (IDF). Static compression therapy is also being administered widely, and is expected to create substantial opportunities for market players during the assessment period.

Key Players in Compression Therapy Market

Paul Hartmann AG, Sigvaris AG, Cardinal Health Inc., and 3M Health Care Ltd are among the leading compression therapy market players. These players are emphasizing on improving their regional and global presence by acquisitions and joint ventures.

For instance –

• In Oct 2019, 3M acquired Acelity, Inc. to expand its reach with regards to effective and safe solutions for improving healthcare economics and clinical outcomes

• In Jun 2017, Cardinal Health announced acquiring Deep Vein Thrombosis – “Patient Care and Nutritional Insufficiency” business of Medtronic for US$ 6.1 Bn
• In Apr 2017, SCA acquired BSN Medical to help the former expand its TENA brand

The Way Forward

The research report on compression therapy market by FMI states that the market will grow at 6% CAGR through 2030. Increase in the number of orthopaedic ailments along with injuries related to sports are expected to drive the market in the upcoming period. Though Covid-19 has slowed down the market for the time being, it is expected to pick up pace from the year 2021.

Innovations will be the key for the market players going forward. Besides, strategic acquisitions and/or partnerships will help the players stand in a good stead in the forecast period.

Key Segment

Product Type

• Pneumatic Compression Therapy
• Non-Segmented Pneumatic Compression Pumps
• Pneumatic Compression Sleeves
• Lower Pneumatic Compression Sleeves
• Upper Pneumatic Compression Sleeves
• Segmented Pneumatic Compression Pumps
• Segmented Pneumatic Compression Pumps with Calibrated Gradient
• Segmented Pneumatic Compression Pumps without Gradient
• Static Compression Therapy
• Anti-Embolism Stockings
• Compression Bandages
• Compression Garments
• Lower Compression Garments
• Upper Compression Garments

Indication

• Chronic Ulcers
• Venous Leg Ulcers
• Diabetic Foot Ulcers
• Pressure Ulcers
• Non-Healing Surgical Wounds
• Traumatic Wounds
• Burn Cases

Distribution Channel

• Institutional Sales
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Nursing Facilities
• Retail Sales
• Hospital Pharmacy
• Retail Pharmacy
• Online Sales

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• MEA